The Canadian Institute of Actuaries (CIA) welcomes this opportunity to offer its inputs on the National Strategy for High-Cost Drugs for Rare Diseases.
The CIA recently released a public statement on the issue of national pharmacare. Although the statement has a wider focus than this consultation, there are elements of our proposal that address the need for access to high-cost drugs and how this should be managed as part of a strategy for drug insurance coverage for all Canadians.
“